IOSPInnospec Inc.

94.73USD+1.17%Mkt Cap: 2.33B $P/E: 19.14

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Che…

HeadlineSourceTime
Older
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours, Avient and Innospec

Stable end-market demand and cost actions are supporting Air Products, DuPont, Avient and Innospec as chemical markets recover.

Zacks
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand

The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.

Zacks
Innospec (IOSP) Q2 2026 Earnings Call Transcript

All three segments posted growth as revenue climbed to $491.4 million.

Motley Fool
Is Innospec (IOSP) Still Undervalued After Its Q2 Earnings Beat?

Innospec stock has climbed 21.2% year to date, yet the latest valuation work suggests the current share price may still sit below an intrinsic value estimate based on a Discounted Cash Flow model, while broader checks point to a more mixed picture. The 21.2% year to date return raises the question of whether recent buyers are already paying up or still getting Innospec at a discount. Recent profit growth and a debt free balance sheet can support the equity story, but any slowdown in segment...

Simply Wall St.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth

Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.

Zacks
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.

Zacks
Innospec Inc (IOSP) (Q2 2026) Earnings Call Highlights: Strong Growth Across All Segments, but ...

Innospec Inc (IOSP) delivers double-digit growth in Q2 2026, yet faces supply constraints and margin headwinds as it navigates plant repairs and pricing challenges.

GuruFocus.com
Innospec Q2 Earnings Call Highlights

Innospec (NASDAQ:IOSP) reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities. Total revenue ro

MarketBeat
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates

Innospec (IOSP) delivered earnings and revenue surprises of +20.95% and +6.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks
IOSP vs. APD: Which Stock Is the Better Value Option?

IOSP vs. APD: Which Stock Is the Better Value Option?

Zacks
IOSP or AIQUY: Which Is the Better Value Stock Right Now?

IOSP vs. AIQUY: Which Stock Is the Better Value Option?

Zacks
Trefis
Zacks